Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

APEIRON, MaxCyte Enter Licensing Agreement for APN401

contractpharmaJuly 10, 2020

Tag: APN401 , Apeiron Biologics , MaxCyte

PharmaSources Customer Service